Altimmune Inc (NASDAQ: ALT) kicked off on Monday, down -6.04% from the previous trading day, before settling in for the closing price of $7.61. Over the past 52 weeks, ALT has traded in a range of $2.34-$14.84.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 115.21%. While this was happening, its average annual earnings per share was recorded 16.83%. With a float of $70.53 million, this company’s outstanding shares have now reached $70.68 million.
Let’s determine the extent of company efficiency that accounts for 59 employees. In terms of profitability, gross margin is -3857.69%, operating margin of -191365.38%, and the pretax margin is -199076.92%.
Altimmune Inc (ALT) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Altimmune Inc is 0.83%, while institutional ownership is 56.02%. The most recent insider transaction that took place on Aug 19 ’24, was worth 110,547. In this transaction Director of this company sold 16,011 shares at a rate of $6.90, taking the stock ownership to the 41,958 shares.
Altimmune Inc (ALT) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 16.83% per share during the next fiscal year.
Altimmune Inc (NASDAQ: ALT) Trading Performance Indicators
Take a look at Altimmune Inc’s (ALT) current performance indicators. Last quarter, stock had a quick ratio of 16.87. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9154.37.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.55, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -1.15 in one year’s time.
Technical Analysis of Altimmune Inc (ALT)
Looking closely at Altimmune Inc (NASDAQ: ALT), its last 5-days average volume was 8.77 million, which is a jump from its year-to-date volume of 3.87 million. As of the previous 9 days, the stock’s Stochastic %D was 23.15%. Additionally, its Average True Range was 0.78.
During the past 100 days, Altimmune Inc’s (ALT) raw stochastic average was set at 31.86%, which indicates a significant increase from 14.86% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 139.11% in the past 14 days, which was higher than the 84.81% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.04, while its 200-day Moving Average is $7.62. However, in the short run, Altimmune Inc’s stock first resistance to watch stands at $7.51. Second resistance stands at $7.87. The third major resistance level sits at $8.16. If the price goes on to break the first support level at $6.87, it is likely to go to the next support level at $6.58. Now, if the price goes above the second support level, the third support stands at $6.22.
Altimmune Inc (NASDAQ: ALT) Key Stats
The company with the Market Capitalisation of 457.72 million has total of 71,125K Shares Outstanding. Its annual sales at the moment are 430 K in contrast with the sum of -88,450 K annual income. Company’s last quarter sales were recorded 10 K and last quarter income was -24,640 K.
